LAURALEE SIBIGA: Open Payments
NPI 1710311923 · SPRINGVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$401 in 20 payments from 11 companies in 2025. Trend: 2023 $631 · 2024 $512 · 2025 $401
Food & beverage: $401
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $97 |
| Novo Nordisk Inc | 3 | $71 |
| Amgen Inc. | 3 | $48 |
| Abbott Laboratories | 2 | $40 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $28 |
| Boston Scientific Corporation | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| ABBVIE INC. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: MOUNJARO, JARDIANCE, OTEZLA, FREESTYLE LIBRE 3, Kerendia, WATCHMAN FLX, AIRSUPRA, VIBERZI.
Industry payments across NY — which companies pay providers there.
